Economic analysis of intermittent intravenous outpatient treatment with levosimendan in advanced heart failure in Spain.
Rev Esp Cardiol (Engl Ed)
; 73(5): 361-367, 2020 May.
Article
in En, Es
| MEDLINE
| ID: mdl-31899185
Key words
Full text:
1
Collection:
01-internacional
Health context:
1_ASSA2030
/
6_ODS3_enfermedades_notrasmisibles
Database:
MEDLINE
Main subject:
Cardiotonic Agents
/
Ambulatory Care
/
Simendan
/
Heart Failure
/
Hydrazones
Type of study:
Clinical_trials
/
Etiology_studies
/
Health_economic_evaluation
/
Prognostic_studies
Limits:
Aged
/
Aged80
/
Female
/
Humans
/
Male
/
Middle aged
Country/Region as subject:
Europa
Language:
En
/
Es
Journal:
Rev Esp Cardiol (Engl Ed)
Year:
2020
Document type:
Article